Tello-Mendoza TA, Vergara-López A, Montoya-Ramírez J, Campos-Barrera E, Guillén-González MA

Language: Spanish
References: 12
Page: 107-114
PDF size: 111.60 Kb.

ABSTRACT

Introduction: Surgical treatment of morbid obesity is an efficacious means of solving or at least significantly improving the comorbidities associated with this condition. Objective: To report the metabolic changes occurring in patients subjected to bariatric surgery at Centro Médico Nacional 20 de Noviembre. Patients and methods: Descriptive, retrospective and comparative study, based on chart review. A database was created which included age, gender, anthropometric measures, blood glucose, insulin, HOMA, total cholesterol, LDL-C, HDL-C and triglycerides at baseline as well as at 1, 3, 6, 9 and 12 months after surgery. Results: Fifty eight patients were included, 74% underwent restrictive surgery whereas in 26% a mixed restrictive-malabsorptive procedure was performed. At one year follow up, the mixed procedure achieved a greater degree of weight loss than the restrictive technique (47 kg vs. 39.8 kg). Glucose and triglycerides levels, as well as HOMA index changed significantly overtime from baseline to the different postoperative evaluations (p = 0.000, p = 0.002, p = 0.002, respectively). Pharmacological treatment could be withdrawn in 83% of diabetic, 65% of hypertensive and 84% of dislipidemic patients. Global mortality was 6.7% and always due to surgical complications. Conclusions: Bariatric surgery significantly improves the control of the different co-morbidities of morbid obesity.

REFERENCES

1. Presutti RJ, Gorman RS, Swain JM. Primary care perspective on bariatric surgery. Mayo Clin Proc 2004; 79: 1158-1166.

2. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.

3. Maggard M, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005; 142: 547-559.

4. Ferranini E, Mingrone G. Impact of different bariatric surgical procedures on insulin action and b-cell function in type 2 diabetes. Diabetes Care 2009; 3: 514-520.

5. Olaiz FG, Rivera DJ, Shamah LT, Rojas R, Villalpando HS, Hernández AM, Sepúlveda AJ. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública, 2006.

6. World Health Organization. Obesity: preventing and managing of the global epidemic. Report of a WHO Consultation presented at: the World Health Organization; 1997; Geneva, Switzerland. Publication WHO/NUT/NCD/98.1.

7. Thompson WG, Cook DA, Clark MM, Bardia A, Levine A. Treatment of obesity. Mayo Clin Proc 2007; 82: 93-102.

8. Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. Comparison of the atkins, ornish, weight watchers, and zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 2005; 293: 43-53.

9. Lau DCW. Synopsis of the 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children. CMAJ 2007; 176: 1103-1106.

10. Alwins S. Gastrointestinal surgery and gut hormones. Curr Opin Endocrinology 2005; 12: 89-98.

11. Brolin RE, Kenler HA, Gorman JH, Cody RP. Long-limb gastric bypass in the superobese. A prospective randomized study. Ann Surg 1992; 215: 387-395.

12. Herrera M, Romero M, Lerman I, Pantoja J, Sierra M et al. Bypass gástrico laparoscópico en Y de Roux en el Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Rev Invest Clin 2009; 63: 186-193.